Versant Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $90.2K | Hold |
|
|||||
|
2025
Q2 | $74.6K | Sell |
|
|||||
|
2025
Q1 | $146K | Hold |
|
|||||
|
2024
Q4 | $162K | Hold |
|
|||||
|
2024
Q3 | $178K | Hold |
|
|||||
|
2024
Q2 | $167K | Hold |
|
|||||
|
2024
Q1 | $171K | Hold |
|
|||||
|
2023
Q4 | $161K | Hold |
|
|||||
|
2023
Q3 | $131K | Hold |
|
|||||
|
2023
Q2 | $150K | Sell |
|
|||||
|
2023
Q1 | $206K | Hold |
|
|||||
|
2022
Q4 | $224K | Hold |
|
|||||
|
2022
Q3 | $214K | Hold |
|
|||||
|
2022
Q2 | $201K | Hold |
|
|||||
|
2022
Q1 | $243K | Buy |
|